Vieri Piazzini
Overview
Explore the profile of Vieri Piazzini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bilia A, Piazzini V, Bergonzi M
Pharmaceutics
. 2020 Dec;
12(12).
PMID: 33287291
Natural products have a wide range of applications with a profound impact in the medical and healthcare fields [...].
2.
Cecchi L, Piazzini V, DAmbrosio M, Luceri C, Rocco F, Innocenti M, et al.
Molecules
. 2020 Jul;
25(14).
PMID: 32668791
The beneficial properties of phenolic compounds from L. are well-known. An olive extract (OE) was prepared from unripe olives (Moraiolo cultivar). The study aimed to formulate OE into a microemulsion...
3.
Piazzini V, Landucci E, Urru M, Chiarugi A, Pellegrini-Giampietro D, Bilia A, et al.
Int J Pharm
. 2020 Apr;
583:119361.
PMID: 32334067
Aripiprazole (ARP) is an antipsychotic drug approved for the treatment of schizophrenia. It is poorly water-soluble and undergoes extensive hepatic metabolism and P-gp efflux, which lead to poor bioavailability and...
4.
Navarro Del Hierro J, Piazzini V, Reglero G, Martin D, Bergonzi M
J Agric Food Chem
. 2020 Jan;
68(5):1297-1305.
PMID: 31934761
The permeability of saponins and sapogenins from fenugreek and quinoa extracts, as well as dioscin and diosgenin, was evaluated by the parallel artificial membrane permeability assay (PAMPA). The effect of...
5.
Maestrelli F, Landucci E, De Luca E, Nerli G, Bergonzi M, Piazzini V, et al.
Pharmaceutics
. 2019 Dec;
11(12).
PMID: 31835593
The transient receptor potential akyrin type-1 (TRPA1) is a non-selective cation channel playing a pivotal role in pain sensation and neurogenic inflammation. TRPA1 channels expressed in the central nervous system...
6.
Piazzini V, Vasarri M, DeglInnocenti D, Guastini A, Barletta E, Salvatici M, et al.
Pharmaceutics
. 2019 Dec;
11(12).
PMID: 31817615
Methods: Chitosan nanoparticles (NP) and Soluplus polymeric micelles (PM) loaded with POE have been developed. Nanoformulations were chemically and physically defined and characterized. In vitro release studies were also performed....
7.
Piazzini V, Micheli L, Luceri C, DAmbrosio M, Cinci L, Ghelardini C, et al.
Int J Pharm
. 2019 Nov;
572:118838.
PMID: 31715362
Silymarin (SLM) is a mixture of flavonolignans extracted from the fruit of Silybum marianum L. Gaertn. which has been used for decades as a hepatoprotector. Silymarin has recently been proposed...
8.
Bilia A, Nardiello P, Piazzini V, Leri M, Bergonzi M, Bucciantini M, et al.
Front Pharmacol
. 2019 Sep;
10:910.
PMID: 31507412
Andrographolide (AG) was encapsulated in human albumin nanoparticles (AG NPs), and their crossing properties of the blood-brain barrier (BBB), brain distribution, and effects in TgCRND8 mice were evaluated. The development...
9.
Piazzini V, DAmbrosio M, Luceri C, Cinci L, Landucci E, Bilia A, et al.
Molecules
. 2019 May;
24(9).
PMID: 31052197
Two novel nanomicellar formulations were developed to improve the poor aqueous solubility and the oral absorption of silymarin. Polymeric nanomicelles made of Soluplus and mixed nanomicelles combining Soluplus with d-α-tocopherol...
10.
Piazzini V, Landucci E, DAmbrosio M, Fasiolo L, Cinci L, Colombo G, et al.
Int J Biol Macromol
. 2019 Feb;
129:267-280.
PMID: 30726749
The aim of the present study was the development of human serum albumin nanoparticles (HSA NPs) as nose-to-brain carrier. To strengthen, the efficacy of nanoparticles as drug delivery system, the...